The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

MSCs decrease lung inflammation. by Konrad Urbanek (439073)

Decreased fibrin deposition in hypoxic C3−/− mice. by Eileen M. Bauer (337320)

hESCs-CM decreased cancer cells growth. by Shufeng Zhou (398572)

Subjects:

Targeting <i>A20</i> decreases glioma stem cell growth. by Anita B. Hjelmeland (104655)

“…Tubulin expression demonstrates equivalent protein loading. (C and D) Cell counts with Trypan Blue staining demonstrates that decreasing expression of A20 reduces the growth of glioma stem cells isolated from T4121 (C) or T08-836 (D) patient specimens passaged short term in immunocompromised mice. …”

Necdin deficiency decreases <i>p16</i> expression and increases <i>Cdk1</i> expression in primary NPCs. by Ryohei Minamide (505053)

Subjects:

Targeting <i>A20</i> decreases glioma stem cell survival. by Anita B. Hjelmeland (104655)

“…An asterisk (*), <i>p</i><0.05 with ANOVA comparison of nontargeting shRNA control to the indicated <i>A20</i> shRNA. (C) Caspase activity relative to cell number as determined in the cell titer assay increased in <i>A20</i> shRNA infected glioma stem cells isolated directly from a T0066-022 patient specimen, but not in matched non-stem glioma cells. …”

Effect of CXCL8 (200 pg/ml), CCL20 (500 pg/ml), CXCL8-CM, and CCL20-CM on osteoclast formation. by Janak L. Pathak (759122)

Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

“…HEK293T cells were transfected with control or C9orf72 shRNA for 72 hours before treatment. Cells were starved for 50 min before being supplemented with amino acids for 10–20 min prior to lysate collection. …”

Caspase-1 activity in cell-extract decreases over time. by Obada R. Shamaa (830382)

Ketamine decreases NSC viability in a dose-dependent manner. by Shiva Mansouri (2838086)

Increased miR200c decreases FAP-1 expression. by Sabarinathan Ramachandran (444500)

Means for STEM competence for pre- and post-test. by Esther Kim (2996622)

Subjects:

Resveratrol decreases PKM2 expression. by Mohd Askandar Iqbal (324124)

“…Western blot showing decreased PKM2 protein in all the cell lines studied on treatment with 50 µM resveratrol (D). …”

Simvastatin decreases eNOS expression. by Mohammed Sabri (355717)

AKT inhibition decreases neuroblast populations. by Maria R. Aburto (186884)

“…Otic vesicles were isolated from HH18 chicken embryos, made quiescent and cultured for 20 h in serum-free culture medium without additions (0S, a) or in the presence of IGF-I (10 nM, b), LY294002 (LY, 25 µM, c) or AKTi VIII (AKTi, 50 µM, d). …”